Clover ups guidance after results

 Q3 2023 Insurance MCR Improved to 78.5%, bringing year-to-date MCR to 80.8%, and Insurance revenue grew 12% compared to Q3 2022

Company reports Q3 2023 Net Loss of $41.5 million and Adjusted EBITDA loss of $5.1 million

Revised full-year 2023 guidance now reflects Insurance MCR of 81% - 82% and Adjusted EBITDA of ($55) million - ($80) million

https://www.globenewswire.com/news-release/2023/11/06/2774493/0/en/Clover-Health-Reports-Third-Quarter-2023-Results-Highlights-Continued-Improvement-in-Financial-Performance-and-Improved-2023-Guidance.html